MCID: PSD007
MIFTS: 53

Pseudomyxoma Peritonei malady

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Pseudomyxoma Peritonei

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Pseudomyxoma Peritonei:

Name: Pseudomyxoma Peritonei 10 45 47 12 51 36 65
Pmp 45 51
Syndrome of Pseudomyxoma Peritonei 45
 
Gelatinous Ascites 51
Mucinous Ascites 10
Adenomucinosis 51

Characteristics:

Orphanet epidemiological data:

51
pseudomyxoma peritonei:
Prevalence: 1-9/1000000 (Worldwide); Age of onset: Adult; Age of death: any age

Classifications:

Orphanet: 51 
Rare tumors


External Ids:

Disease Ontology10 DOID:3559
MeSH36 D011553
NCIt42 C3345
Orphanet51 26790
ICD10 via Orphanet28 C78.6
MESH via Orphanet37 D011553
UMLS via Orphanet66 C0033822
UMLS65 C0033822

Summaries for Pseudomyxoma Peritonei

About this section
NIH Rare Diseases:45 Pseudomyxoma peritonei (pmp) is a rare condition characterized by the presence of mucin in the abdominal (peritoneal) cavity. while the most common cause of pmp is appendix cancer, several types of tumors (including non-cancerous tumors) can cause pmp. signs and symptoms may include an increase in abdominal size or bloating; inguinal hernia (in men); an ovarian mass, felt during a routine pelvic exam (in women); pain or discomfort in the abdomen; and/or appendicitis. treatment depends on the underlying cause of the condition (the location and type of the original tumor, including whether it is malignant) and the extent of spreading. it may involve surgically removing as much of the tumor as possible (debulking); radiotherapy; and/or chemotherapy. last updated: 4/11/2016

MalaCards based summary: Pseudomyxoma Peritonei, also known as pmp, is related to klatskin's tumor and pancreatic ductal adenocarcinoma, and has symptoms including ascites, abnormality of the peritoneum and abnormality of the abdominal wall. An important gene associated with Pseudomyxoma Peritonei is MUC2 (Mucin 2, Oligomeric Mucus/Gel-Forming), and among its related pathways are Cell adhesion_Cadherin-mediated cell adhesion and FGF signaling pathway. Affiliated tissues include appendix, colon and small intestine, and related mouse phenotypes are tumorigenesis and digestive/alimentary.

Disease Ontology:10 An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis.

Wikipedia:68 Pseudomyxoma peritonei (PMP) is a clinical condition caused by cancerous cells (mucinous adenocarcinoma)... more...

Related Diseases for Pseudomyxoma Peritonei

About this section

Diseases related to Pseudomyxoma Peritonei via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 500)
idRelated DiseaseScoreTop Affiliating Genes
1klatskin's tumor30.2CDX2, KRAS, MUC2
2pancreatic ductal adenocarcinoma29.8CDH1, KRAS, TP53
3esophageal cancer29.3CDH1, CDX2, KRAS, TP53
4hepatocellular carcinoma29.2CDH1, KRT7, MCL1, TP53
5prostate cancer29.0CDH1, CDH2, KRAS, MCL1, TP53
6colorectal cancer28.4CDH1, CDX2, KRAS, MCL1, MUC2, TP53
7mucinous adenocarcinoma11.6
8gelatinous ascites11.6
9leukemia10.6
10breast cancer10.5
11esophagitis10.5
12lymphoma10.5
13adenocarcinoma10.5
14cervicitis10.4
15retinitis10.4
16neuronitis10.4
17cutaneous mucoepidermoid carcinoma10.4KRT7, MUC2
18sarcoma10.4
19prostatitis10.4
20tuberculosis10.4
21adenoma10.4
22influenza10.4
23myeloid leukemia10.4
24tricuspid valve stenosis10.4KRT7, MUC2
25pancreatic invasive mucinous cystadenocarcinoma10.4KRT7, MUC2
26osteoclast-like giant cell neoplasm of the pancreas10.3KRAS, MUC2
27malignant giant cell tumor of soft parts10.3KRAS, KRT7
28serous surface papilloma10.3KRAS, KRT7
29bronchial mucus gland adenoma10.3CDX2, MUC2
30gastric cancer10.3
31hepatitis10.3
32ulcerative colitis10.3
33colitis10.3
34melanoma10.3
35transitional cell carcinoma10.3
36thyroiditis10.3
37vasculitis10.3
38leishmaniasis10.3
39meningitis10.3
40cardiomyopathy10.3
41endotheliitis10.3
42gastric cancer risk after h. pylori infection10.3CDH1, KRAS
43ampulla of vater mucinous adenocarcinoma10.3CDX2, KRT7
44cervical mullerian papilloma10.3CDX2, MUC2
45duodenum adenoma10.3CDX2, KRT7
46nodular tenosynovitis10.3CDX2, KRT7
47lacrimal passage granuloma10.3KRAS, MUC2
48bronchiolo-alveolar adenocarcinoma10.3CDX2, KRT7
49aortitis10.3CDX2, KRT7
50malignant peritoneal solitary fibrous tumor10.3CDH1, KRT7

Graphical network of the top 20 diseases related to Pseudomyxoma Peritonei:



Diseases related to pseudomyxoma peritonei

Symptoms for Pseudomyxoma Peritonei

About this section

Symptoms:

 51 (show all 19)
  • anomalies of the abdominal wall
  • ascitis
  • peritoneal diseases
  • inflammatory intestinal disease
  • herniae
  • nausea/vomiting/regurgitation/merycism/hyperemesis
  • acute abdominal pain/colic
  • constipation
  • intestinal obstruction/ileus
  • respiratory distress/dyspnea/respiratory failure/lung volume reduction
  • lymphadenopathy/polyadenopathies
  • pollakiuria/polyuria/dysuria/anuria/acute urine retention/oliguria
  • digestive neoplasm/tumor/carcinoma/cancer
  • estomach/gastric neoplasm/tumor/carcinoma/cancer
  • colon neoplasm/tumor/carcinoma/cancer
  • pancreatic/pancreas neoplasm/tumor/carcinoma/cancer
  • ovary/fallopian tube neoplasm/tumor/carcinoma/cancer (excl. teratoma/germinoma)
  • early death/lethality
  • weight loss/loss of appetite/break in weight curve/general health alteration

HPO human phenotypes related to Pseudomyxoma Peritonei:

(show all 17)
id Description Frequency HPO Source Accession
1 ascites hallmark (90%) HP:0001541
2 abnormality of the peritoneum hallmark (90%) HP:0002585
3 abnormality of the abdominal wall hallmark (90%) HP:0004298
4 inflammation of the large intestine typical (50%) HP:0002037
5 weight loss occasional (7.5%) HP:0001824
6 nausea and vomiting occasional (7.5%) HP:0002017
7 constipation occasional (7.5%) HP:0002019
8 abdominal pain occasional (7.5%) HP:0002027
9 respiratory insufficiency occasional (7.5%) HP:0002093
10 lymphadenopathy occasional (7.5%) HP:0002716
11 neoplasm of the pancreas occasional (7.5%) HP:0002894
12 intestinal obstruction occasional (7.5%) HP:0005214
13 neoplasm of the stomach occasional (7.5%) HP:0006753
14 abnormal renal physiology occasional (7.5%) HP:0012211
15 neoplasm of the colon occasional (7.5%) HP:0100273
16 ovarian neoplasm occasional (7.5%) HP:0100615
17 hernia occasional (7.5%) HP:0100790

Drugs & Therapeutics for Pseudomyxoma Peritonei

About this section

Drugs for Pseudomyxoma Peritonei (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Oxaliplatinapproved, investigationalPhase 2, Phase 1132261825-94-35310940, 9887054, 6857599, 43805, 6857599, 9887054
Synonyms:
CHEMBL1201055
CID9887054
D01790
DACPLAT
Diaminocyclohexane Oxalatoplatinum
Eloxatin
Eloxatin (TN)
Elplat
Foloxatine
L-OHP
 
Oxalatoplatin
Oxalatoplatinum
Oxaliplatin
Oxaliplatin (JAN/USAN/INN)
Oxaliplatin [Usan:Inn:Ban]
Oxaliplatino [Spanish]
Oxaliplatinum [Latin]
Oxaloplatine [French]
Oxaloplatino [Spanish]
Transplatin
oxaliplatin
2
leucovorinapprovedPhase 2, Phase 19521492-18-854575
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid-SF
Fusilev
 
L-Folinic acid
L-leucovorin
Leucal
Leucovorin
Leucovorin Calcium
Leucovorin calcium
Leucovorin folinic acid
Leucovorin sodium
Leukovorin
Levofolene
Levofolinic acid
Levoleucovorin
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
Wellcovorin
3
Lansoprazoleapproved, investigationalPhase 2198103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Careone Lansoprazole
Compraz
D00355
DB00448
Dakar
Dg Health Lansoprazole
DivK1c_000920
EU-0100709
Equaline Lansoprazole
Equate Lansoprazole Delayed Release
Exchange Select Lansoprazole
FT-0082011
Good Neighbor Pharmacy Lansoprazole
Good Sense Lansoprazole
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Health Mart Lansoprazole
Healthy Accents Lansoprazole
Heartburn Relief 24 Hour
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
Kirkland Signature Lansoprazole Delayed Release
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole Heartburn Relief 24 Hour
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
 
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Leader Lansoprazole
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Preferred Plus Lansoprazole
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid 24 HR
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
Rugby Heartburn Treatment
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Shoprite Lansoprazole
Simply Right Lansoprazole
Smart Sense Acid Reducer
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Sunmark Lansoprazole
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
Topcare Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Well At Walgreens Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
4
AmoxicillinapprovedPhase 239126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
5
ClarithromycinapprovedPhase 224681103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
6
FluorouracilapprovedPhase 2168451-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
7Anti-Infective AgentsPhase 2, Phase 117220
8Antimetabolites, AntineoplasticPhase 2, Phase 15770
9Immunologic FactorsPhase 2, Phase 118483
10Immunosuppressive AgentsPhase 2, Phase 110422
11AntimetabolitesPhase 2, Phase 19454
12Anti-Bacterial AgentsPhase 29140
13Cytochrome P-450 CYP3A InhibitorsPhase 21421
14Antibiotics, AntitubercularPhase 25971
15Cytochrome P-450 Enzyme InhibitorsPhase 23036
16
DexlansoprazolePhase 2198138530-94-6, 103577-45-39578005
Synonyms:
138530-94-6
CHEMBL1201863
CID9578005
D08903
Dexlansoprazole (INN/USAN)
KS-1075
 
Kapidex
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
dexlansoprazole
17Antitubercular AgentsPhase 21061
18MitomycinsPhase 2219
19Alkylating AgentsPhase 23582
20Nucleic Acid Synthesis InhibitorsPhase 23836
21
FloxuridineapprovedPhase 14750-91-95790
Synonyms:
1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil
1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil
1beta-D-2'-Deoxyribofuranosyl-5-flurouracil
2'-Deoxy-5-fluorouridine
5 Fluorodeoxyuridine
5-FUDR
5-Fluoro-2-desoxyuridine
5-Fluorodeoxyuridine
5-Fluorouracil 2'-deoxyriboside
5-Fluorouracil deoxyriboside
5FDU
Deoxyfluorouridine
 
FDUR
FDURD
FUDR
FdU
Floxiridina
Floxiridina [INN-Spanish]
Floxuridin
Floxuridine
Floxuridinum
Floxuridinum [INN-Latin]
Fluorodeoxyuridine
Fluoruridine Deoxyribose
WR-138720
beta-5-Fluoro-2'-deoxyuridine
22
GemcitabineapprovedPhase 1188195058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine Hydrochloride
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
23
CarboplatinapprovedPhase 1188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
24LevoleucovorinPhase 1676
25Liver ExtractsPhase 13572
26Antiviral AgentsPhase 18071
27Calcium, DietaryPhase 14678
28Protective AgentsPhase 15651
29pancreatic polypeptidePhase 120
30Folinic AcidNutraceuticalPhase 12604
31ColaNutraceuticalPhase 11768

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal OriginRecruitingNCT02387203Phase 2
2Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-CEnrolling by invitationNCT02040142Phase 2
3A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2
4Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
5Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
6Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789
7Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346
8Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was PerformedRecruitingNCT01617382
9Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
10Results of CRS and Debulking in PMP PatientsActive, not recruitingNCT01427101
11Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC PatientsEnrolling by invitationNCT02374411
12Gastrointestinal Microbiome Study of Appendiceal CancerNot yet recruitingNCT02599116

Search NIH Clinical Center for Pseudomyxoma Peritonei


Cochrane evidence based reviews: pseudomyxoma peritonei

Genetic Tests for Pseudomyxoma Peritonei

About this section

Anatomical Context for Pseudomyxoma Peritonei

About this section

MalaCards organs/tissues related to Pseudomyxoma Peritonei:

33
Appendix, Colon, Small intestine, Breast, Liver, Pancreas, Lung

Animal Models for Pseudomyxoma Peritonei or affiliated genes

About this section

MGI Mouse Phenotypes related to Pseudomyxoma Peritonei:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.4CDH1, CDX2, KRAS, MUC2, TP53
2MP:00053818.3CDH1, CDX2, KRAS, MUC2, TP53
3MP:00028737.9CDH1, CDX2, KRAS, MCL1, TP53
4MP:00053797.6CDH1, CDX2, KRAS, MCL1, MUC2, TP53
5MP:00053857.6CDH1, CDH2, CDX2, KRAS, MUC2, TP53
6MP:00053807.5CDH1, CDH2, CDX2, KRAS, MCL1, TP53
7MP:00053767.1CDH1, CDH2, CDX2, KRAS, KRT7, MUC2
8MP:00053846.5CDH1, CDH2, CDX2, KRAS, KRT7, MCL1
9MP:00107686.5CDH1, CDH2, CDX2, KRAS, MCL1, MUC2

Publications for Pseudomyxoma Peritonei

About this section

Articles related to Pseudomyxoma Peritonei:

(show top 50)    (show all 537)
idTitleAuthorsYear
1
Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study. (25819708)
2015
2
Radiopharmaceuticals in paraganglioma imaging: too many members on board? (26459050)
2015
3
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies. (26541752)
2015
4
A common cancer-associated DNA polymerase I/ mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading. (24525744)
2014
5
miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment. (24631181)
2014
6
Reversing LRP5-Dependent Osteoporosis and SOST Deficiency-Induced Sclerosing Bone Disorders by Altering WNT Signaling Activity. (23901037)
2014
7
Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis. (24459820)
2013
8
Item-level psychometric properties for a new patient-reported psoriasis symptom diary. (24041351)
2013
9
Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation. (22508549)
2012
10
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts. (22032879)
2012
11
Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. (22300696)
2012
12
Failure to induce IFN-I^ production during Staphylococcus aureus infection contributes to pathogenicity. (23008447)
2012
13
Cataract-causing defect of a mutant I^-crystallin proceeds through an aggregation pathway which bypasses recognition by the I+-crystallin chaperone. (22655036)
2012
14
In reference to Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. (20927780)
2010
15
Association of the mitochondrial transcription factor (TFAM) gene polymorphism with physical performance of athletes]. (20432700)
2010
16
Normal pressure hydrocephalus after radiosurgery for sphenoid ridge meningioma. (19013812)
2009
17
Estrogen-dependent and -independent estrogen receptor-alpha signaling separately regulate male fertility. (19264877)
2009
18
Prevalence of dry eye disease among Japanese visual display terminal users. (18708259)
2008
19
Functional retrograde amnesia: a multiple case study. (18387529)
2008
20
Ultrasonographic documentation of a spontaneously resolved peripheral senescent retinoschisis. (18982048)
2008
21
Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease. (18325185)
2008
22
Quantitation with QUEST of brain HRMAS-NMR signals: application to metabolic disorders in experimental epileptic seizures. (18506844)
2008
23
Strategies to manage major obstetric haemorrhage. (18458542)
2008
24
DNA-based diagnosis of mucolipidosis type IIIA and mucopolysacchariodisis type VI in a Chinese family: a chance of 1 in 7.6 trillion. (17034777)
2007
25
Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. (16519819)
2006
26
No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in Caucasian females. (17201588)
2006
27
Acute spinal cord compression in hereditary multiple exostoses. (16311838)
2006
28
Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. (16199034)
2006
29
Protein kinase Czeta attenuates hypoxia-induced proliferation of fibroblasts by regulating MAP kinase phosphatase-1 expression. (16467381)
2006
30
Thymidine phosphorylase gene mutations cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). (17077575)
2006
31
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. (16363236)
2005
32
Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome. (15770227)
2005
33
Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). (15248100)
2004
34
A curious case of ascites. Chylous ascites caused by Kaposi's sarcoma. (12647476)
2003
35
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. (12440486)
2002
36
Effects of methylprednisolone on intracellular bacterial growth. (11687457)
2001
37
An established case of dentatorubral pallidoluysian atrophy (DRPLA) with unusual features on muscle biopsy. (10872107)
2000
38
Follicular hormonal environment and embryo quality in women with endometriosis. (10711831)
2000
39
Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. (10022835)
1999
40
Mutational analysis of cysteine-string protein function in insulin exocytosis. (10194413)
1999
41
p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. (9664901)
1998
42
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. (9701270)
1998
43
Allergic bronchopulmonary aspergillosis: an unusual complication of bronchial asthma. (8920604)
1995
44
Functional interaction between interleukin-9/P40 and interleukin-4 in the induction of IgE production by normal human B lymphocytes. (8374511)
1993
45
Thin basement membrane nephropathy as a cause of recurrent haematuria in childhood. (2361650)
1990
46
Intermembrane cholesterol transfer: role of sterol carrier proteins and phosphatidylserine. (2280670)
1990
47
The plasmacytoid T cell or plasmacytoid monocyte--a sessile lymphoid cell with unique immunophenotype and unknown function, still awaiting lineage affiliation. (2292193)
1990
48
Clinico-pathological study of atypical membranoproliferative glomerulonephritis. (3613256)
1987
49
Treatment of keratoacanthoma with intralesional bleomycin. (6194810)
1983
50
Seizure disorder in mothers of children with orofacial clefts: a case-control study. (4810733)
1974

Variations for Pseudomyxoma Peritonei

About this section

Cosmic variations for Pseudomyxoma Peritonei:

7 (show top 50)    (show all 110)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Conf
1COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
2COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
3COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
4COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
5COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
6COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
7COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
8COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
9COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
10COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
11COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
12COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
13COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
14COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
15COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
16COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
17COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
18COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
19COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
20COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
21COSM522KRASperitoneum,appendix,other,pseudomyxoma peritonei1
22COSM12722KRASperitoneum,appendix,other,pseudomyxoma peritonei1
23COSM546KRASperitoneum,colon,other,pseudomyxoma peritonei1
24COSM539KRASperitoneum,appendix,other,pseudomyxoma peritonei1
25COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
26COSM51382KRASperitoneum,appendix,other,pseudomyxoma peritonei1
27COSM110699KRASperitoneum,appendix,other,pseudomyxoma peritonei1
28COSM1562184KRASperitoneum,appendix,other,pseudomyxoma peritonei1
29COSM1360888KRASperitoneum,appendix,other,pseudomyxoma peritonei1
30COSM1169214KRASperitoneum,appendix,other,pseudomyxoma peritonei1
31COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
32COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
33COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
34COSM529KRASperitoneum,appendix,other,pseudomyxoma peritonei1
35COSM527KRASperitoneum,appendix,other,pseudomyxoma peritonei1
36COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
37COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
38COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
39COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
40COSM532KRASperitoneum,appendix,other,pseudomyxoma peritonei1
41COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
42COSM521KRASperitoneum,appendix,other,pseudomyxoma peritonei1
43COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
44COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
45COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
46COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
47COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
48COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
49COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1
50COSM520KRASperitoneum,appendix,other,pseudomyxoma peritonei1

Expression for genes affiliated with Pseudomyxoma Peritonei

About this section
Search GEO for disease gene expression data for Pseudomyxoma Peritonei.

Pathways for genes affiliated with Pseudomyxoma Peritonei

About this section

GO Terms for genes affiliated with Pseudomyxoma Peritonei

About this section

Biological processes related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1striated muscle cell differentiationGO:00511469.6CDH2, KRAS
2adherens junction organizationGO:00343329.3CDH1, CDH2

Molecular functions related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1gamma-catenin bindingGO:00452959.3CDH1, CDH2

Sources for Pseudomyxoma Peritonei

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet